Delhi HC restrains Zydus from launching Dabrafenib till patent expiry ...Middle East

Zydus undertakes not to commercially manufacture or launch Dabrafenib until Novartis' Indian patent expires in May 2029; statutory Bolar rights remain protected

Hence then, the article about delhi hc restrains zydus from launching dabrafenib till patent expiry was published today ( Tuesday 18/08/2026 - 05:21 PM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Delhi HC restrains Zydus from launching Dabrafenib till patent expiry )

Also on site :

• Brent Tops $91 After Unidentified Projectile Hits Vessel Transiting Hormuz
• Father of Modern Marketing Philip Kotler & ATLAS SkillTech University Professor Dr. Varsha Agarwal Co-Author B2B Brand Management Book
• NEXTDC Receives Frost & Sullivan's 2026 Australia Competitive Strategy Leadership Recognition for Excellence in Data Center Services Innovation and Growth